Subsequent studies employing integrated metabolic profiling (e.g., oxygen consumption rate detection assays) could comprehensively characterize the role of the NR6A1-mTOR axis in tumor cell metabolic reprogramming. The gene discussed is NR6A1; the disease is neoplasm.